Yuan-Fang Xing

Lung organoids for preclinical evaluation of stem cell therapies: Opportunities, evidence, and translational challenges

Pulmonary diseases impose a substantial global burden and remain major causes of morbidity and mortality. Despite advances in disease-modifying therapies, effective regenerative treatments remain limited for several chronic lung diseases, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease...